Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CML-IN-1, also known as compound 7 and compound 4, is a potent anticancer agent that demonstrates a strong induced-apoptosis effect in the human chronic myeloid leukemia (CML) cell line K562. It diminishes protein phosphorylation within the PI3K/Akt signaling pathway to exert its effects and suppresses cell proliferation through the inhibition of the MEK/ERK signaling pathway in colorectal cancer [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | CML-IN-1, also known as compound 7 and compound 4, is a potent anticancer agent that demonstrates a strong induced-apoptosis effect in the human chronic myeloid leukemia (CML) cell line K562. It diminishes protein phosphorylation within the PI3K/Akt signaling pathway to exert its effects and suppresses cell proliferation through the inhibition of the MEK/ERK signaling pathway in colorectal cancer [1] [2]. |
In vitro | CML-IN-1 (compound 7) exhibited the least cytotoxicity and enhanced bioactivity in cellular assays (K562, IC50: 0.038 µM) [1]. CML-IN-1 (compound 4) significantly inhibited the proliferation of HCT116 cells with IC50 values of 8.04 ± 0.94 µM at 48 hours and 5.52 ± 0.42 µM at 72 hours [2]. Additionally, CML-IN-1 (compound 4) suppressed colony formation, migration, and invasion of HCT116 cells in a dose-dependent manner, induced apoptosis, and caused cell cycle arrest at the G2/M phase [2]. It also inhibited the activation of MEK/ERK signaling pathways in HCT116 cells [2]. |
Molecular Weight | 540.58 |
Formula | C21H23F3N8O2S2 |
CAS No. | 2235393-30-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Anticancer agent 164 2235393-30-1 Apoptosis inhibitor inhibit